• Venue:TBA (To Be Announced) / TBC (To Be Confirmed)
  • Address:
  • City:Beijing
  • Industry:Health & Medicine, Marketing & Retail, Conference & Summit / Congress
  • Date:2015/07/02 - 2015/07/03
  • Organizer: Marcus Evans Group
  • Official Website:
  • E-mail: sharonc@marcusevanskl.com
  • Tel:+603-2723 6757; +91-22-4231 7750
  • Fax:+603-2723 6699

Market Access and Commercial Strategy for Healthcare Industry conference 2015

 

Exhibition / Event / Trade Show's Profile

Aims to enhance market access and commercial effectiveness in the ever evolving healthcare landscape for maximised value and profitability, Market Access and Commercial Strategy for Healthcare Industry conference 2015 will be staged on July 2-3, 2015 in Beijing, China.

Market Access and Commercial Strategy for Healthcare Industry conference 2015 is the best platform understanding the key characteristics of market access in the healthcare industry and planning an effective commercial strategy, the conference will invite senior government representatives, experts in market access, regulatory affairs, strategic planning, commercial excellence, sales and marketing from the leading pharmaceutical and medical device companies.

Hot Topics of Market Access and Commercial Strategy for Healthcare Industry conference :
■Continuously Identifying, Monitoring and Mapping the Value Drivers for Diverse Stakeholders
■Evaluating Possible Changes, Future Trends and the Potential Impact of New Regulations on Healthcare Organisations
■Maximising Revenue and Profit through Enhanced Product Lifecycle Management (PLM)
■Developing the Most Advantageous Pricing Strategy with a Comprehensive Consideration
■Establishing Unmet Needs in the Market and Developing a Strategy to Maximise Opportunities 

Visitors' Profile

Previous Attendees Include:
AbbVie, Astellas, Bard, Baxter, Bayer Healthcare, Bide Pharmatech, Cardinal Heath, Coldplast, Ever Neuro Pharma, Fresenius Kabi, GSK, Ipsen, Johnson & Johnson, Kyowa Kirin, Novo Nordisk, Ortho Clinical, Sanofi, Servier, Sinovac, Synthasia, UCB Pharma, Xian-Janssen

Go to top